These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38410204)

  • 41. Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature.
    Lu L; Zhang P; Cao X; Guan M
    J Oncol; 2022; 2022():1539659. PubMed ID: 35432539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Cao Y; Dai Z; Xie G; Liu G; Guo L; Zhang J
    Exp Cell Res; 2023 Jul; 428(2):113628. PubMed ID: 37149080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
    Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
    Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
    Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
    PeerJ; 2023; 11():e16237. PubMed ID: 37842043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A composite score based on immune-related gene prognostic index and m
    Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z
    Front Genet; 2023; 14():1061569. PubMed ID: 36845378
    [No Abstract]   [Full Text] [Related]  

  • 48. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
    Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
    Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
    Zhong Q; Zhou L; Zhu D
    J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
    Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
    Li SR; Man QW; Liu B
    Front Oncol; 2022; 12():943945. PubMed ID: 36452497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Prognostic Signature of Head and Neck Squamous Cell Carcinoma Constructed by Immune-Related RNA-Binding Proteins.
    Ming R; Li X; Wang E; Wei J; Liu B; Zhou P; Yu W; Zong S; Xiao H
    Front Oncol; 2022; 12():795781. PubMed ID: 35449571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck.
    Li C; Wang X; Qin R; Zhong Z; Sun C
    Front Genet; 2021; 12():698040. PubMed ID: 34539737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
    Zhu C; Wu Q; Yang N; Zheng Z; Zhou F; Zhou Y
    Front Genet; 2022; 13():848841. PubMed ID: 35586567
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
    Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
    Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.